Status
Conditions
Treatments
About
this randomized controlled trial aims to compare the effectiveness of High-Intensity Laser Therapy (HILT) and Extracorporeal Shockwave Therapy (ESWT) in managing patients with Myofascial Pain Syndrome (MPS). Thirty-two participants will be randomly assigned to receive either HILT or ESWT over a period of 4 weeks. Outcome measures include pain intensity (Visual Analog Scale), tenderness, functional disability, and cervical range of motion.
Full description
This randomized controlled trial aims to compare the efficacy of High-Intensity Laser Therapy (HILT) and Extracorporeal Shockwave Therapy (ESWT) in the management of patients with Myofascial Pain Syndrome (MPS) of the neck and shoulder region. Thirty-two participants will be randomly allocated into two groups: one receiving HILT and the other receiving ESWT, with both groups undergoing 8 treatment sessions over 4 weeks. The primary outcome is pain intensity assessed by the Visual Analog Scale (VAS). Secondary outcomes include tenderness (PPT), functional disability (Neck Disability Index), and cervical range of motion (measured by CROM). The study will be conducted at the Faculty of Physical Therapy, Benha University.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Male and female participants aged 18-60 years. Diagnosis of Myofascial Pain Syndrome (MPS) in the neck/shoulder region. Presence of active myofascial trigger points in the upper trapezius. Willingness to provide informed consent.
Exclusion criteria
History of cervical spine surgery, trauma, or radiculopathy. Contraindications to laser or shockwave therapy. Presence of systemic diseases (e.g., rheumatoid arthritis, malignancy). Receiving other physical therapy interventions during the study period
Primary purpose
Allocation
Interventional model
Masking
32 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal